A 25-year-long observational study, recently published in the journal, PLOS Medicine, reported that less than 5 hours of sleep at night is associated with ≥30% increased risk of multiple chronic diseases such as diabetes, coronary heart disease, heart failure, stroke, chronic kidney disease, etc., in the middle-aged and elderly individuals. This study included participants from […]
One in seven Indian patients with acute decompensated heart failure (ADHF) died within 3 months of hospital admission, reported a study by Harikrishnan et al., published in the journal European Society of Cardiology (ESC) Heart Failure. The study was conducted among 10,851 patients with ADHF (mean age: 59.9 years) from the largest heart failure (HF)
A study published recently in The New England Journal of Medicine(NEJM) reported that treatment with dapagliflozin, a sodium–glucose transporter 2 (SGLT2) inhibitor, reduced the risk of cardiovascular (CV) outcomes in patients with heart failure (HF) and left ventricular ejection fraction (LVEF) >40%. The interventional study, Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved
A recent study published in JAMA Neurology reported that walking 9,826 steps a day can lower the risk of dementia by half. In addition, steps of higher intensity can further reduce the incident risk. This prospective, observational cohort study, conducted by Del Pozo Cruz B et al. included 78,430 adults (40–79 years of age) from
Walk 9,826 steps a day to reduce dementia risk by 50% Read More »